Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

SELL
$7.7 - $37.13 $2.74 Million - $13.2 Million
-355,960 Closed
0 $0
Q3 2021

Nov 03, 2021

BUY
$26.46 - $37.15 $264,600 - $371,500
10,000 Added 2.89%
355,960 $12.1 Million
Q2 2021

Jul 30, 2021

BUY
$32.73 - $47.95 $39,275 - $57,540
1,200 Added 0.35%
345,960 $12.7 Million
Q1 2021

Apr 30, 2021

BUY
$40.39 - $56.73 $3.71 Million - $5.22 Million
91,950 Added 36.37%
344,760 $15.5 Million
Q4 2020

Jan 29, 2021

BUY
$51.77 - $66.18 $1.88 Million - $2.4 Million
36,225 Added 16.73%
252,810 $14.4 Million
Q3 2020

Oct 30, 2020

BUY
$43.8 - $58.16 $996,449 - $1.32 Million
22,750 Added 11.74%
216,585 $11.1 Million
Q2 2020

Aug 03, 2020

SELL
$37.05 - $65.03 $51,499 - $90,391
-1,390 Reduced 0.71%
193,835 $11.6 Million
Q1 2020

Apr 30, 2020

BUY
$33.63 - $69.4 $1.16 Million - $2.39 Million
34,370 Added 21.37%
195,225 $8.04 Million
Q4 2019

Jan 31, 2020

SELL
$31.7 - $69.93 $1.52 Million - $3.35 Million
-47,899 Reduced 22.95%
160,855 $10 Million
Q3 2019

Nov 04, 2019

SELL
$19.95 - $38.85 $79,700 - $155,205
-3,995 Reduced 1.88%
208,754 $7.09 Million
Q2 2019

Jul 31, 2019

SELL
$21.05 - $26.21 $18,313 - $22,802
-870 Reduced 0.41%
212,749 $4.8 Million
Q1 2019

May 01, 2019

SELL
$20.65 - $29.55 $3,097 - $4,432
-150 Reduced 0.07%
213,619 $4.96 Million
Q4 2018

Jan 31, 2019

BUY
$19.08 - $36.14 $484,822 - $918,317
25,410 Added 13.49%
213,769 $4.49 Million
Q2 2018

Aug 02, 2018

SELL
$20.06 - $44.95 $89,969 - $201,600
-4,485 Reduced 2.33%
188,359 $7.41 Million
Q1 2018

Apr 30, 2018

SELL
$20.04 - $29.71 $365,830 - $542,356
-18,255 Reduced 8.65%
192,844 $3.87 Million
Q4 2017

Jan 31, 2018

BUY
$16.54 - $24.2 $1.6 Million - $2.34 Million
96,749 Added 84.61%
211,099 $4.79 Million
Q3 2017

Oct 31, 2017

BUY
$17.65 - $18.99 $2.02 Million - $2.17 Million
114,350
114,350 $2.17 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.